LOW-FREQUENCY OF GERMLINE MUTATIONS IN THE RET PROTOONCOGENE IN PATIENTS WITH APPARENTLY SPORADIC MEDULLARY-THYROID CARCINOMA

被引:123
作者
ENG, C
MULLIGAN, LM
SMITH, DP
HEALEY, CS
FRILLING, A
RAUE, F
NEUMANN, HPH
PONDER, MA
PONDER, BAJ
机构
[1] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DEPT MED,BOSTON,MA 02115
[2] QUEENS UNIV,DEPT PAEDIAT,KINGSTON,ON K7L 3N6,CANADA
[3] QUEENS UNIV,DEPT PATHOL,KINGSTON,ON K7L 3N6,CANADA
[4] UNIV HAMBURG,KRANKENHAUS EPPENDORF,CHIRURG KLIN,W-2000 HAMBURG 20,GERMANY
[5] UNIV HEIDELBERG,MED KLIN & POLIKLIN,HEIDELBERG,GERMANY
[6] UNIV FREIBURG,INNERE MED NEPHROL ABT 4,D-79106 FREIBURG,GERMANY
关键词
D O I
10.1111/j.1365-2265.1995.tb01903.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND AND OBJECTIVES Medullary thyroid carcinoma (MTC) occurs both sporadically and in the autosomal dominantly inherited multiple endocrine neoplasia (MEN) type 2 syndromes. The distinction between true sporadic MTC and a new mutation familial case is important for future clinical managment of both the patient and family. The susceptibility gene for MEN 2 is the RET proto-oncogene. Systematic analysis for germline mutations of the RET proto-oncogene was performed in a series of 67 patients with apparently sporadic MTC to determine whether they were true sporadic cases or unsuspected de novo MEN 2 cases. DESIGN AND PATIENTS Sixty-seven unselected patients with sporadic MTC were randomly ascertained from clinic patients from four centres. The diagnosis of MTC was confirmed by histopathology. Germline DNA was extracted from peripheral blood leucocytes or from paraffin-embedded tissue and subsequently used for polymerase chain reaction amplification. MEASUREMENTS Polymerase chain reaction based RET mutation analysis was performed by direct double-stranded cycle sequencing of exons 10, 11, 13 and 16, within which the majority of MEN2 mutations have been shown to occur. RESULTS In this series, there was one proven case of germline mutation in RET codon 620, which previously has been shown to be responsible for MEN 2, thus indicating heritable disease. No germline mutation in codon 918, typical of MEN 2B, was found. CONCLUSlONS A figure of 1.5% germline mutations in 67 apparently sporadic MTC is lower than the incidence of familial disease reported in previous series involving clinical and biochemical screening. The presence of a germline mutation in the RET proto-oncogene in a patient with MTC indicates heritable disease. The absence of germline RET exon 10, 11, 13 or 16 mutation appears to rule out MEN 2A to a high probability, although the presence of a familial form of MTC other than classical MEN 2A cannot be excluded conclusively.
引用
收藏
页码:123 / 127
页数:5
相关论文
共 20 条
  • [1] SINGLE MISSENSE MUTATION IN THE TYROSINE KINASE CATALYTIC DOMAIN OF THE RET PROTOONCOGENE IS ASSOCIATED WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B
    CARLSON, KM
    DOU, SS
    CHI, D
    SCAVARDA, N
    TOSHIMA, K
    JACKSON, CE
    WELLS, SA
    GOODFELLOW, PJ
    DONISKELLER, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (04) : 1579 - 1583
  • [2] MUTATIONS IN THE RET PROTOONCOGENE ARE ASSOCIATED WITH MEN 2A AND FMTC
    DONISKELLER, H
    DOU, SS
    CHI, D
    CARLSON, KM
    TOSHIMA, K
    LAIRMORE, TC
    HOWE, JR
    MOLEY, JF
    GOODFELLOW, P
    WELLS, SA
    [J]. HUMAN MOLECULAR GENETICS, 1993, 2 (07) : 851 - 856
  • [3] POINT MUTATION WITHIN THE TYROSINE KINASE DOMAIN OF THE RET PROTOONCOGENE IN MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B AND RELATED SPORADIC TUMORS
    ENG, C
    SMITH, DP
    MULLIGAN, LM
    NAGAI, MA
    HEALEY, CS
    PONDER, MA
    GARDNER, E
    SCHEUMANN, GFW
    JACKSON, CE
    TUNNACLIFFE, A
    PONDER, BAJ
    [J]. HUMAN MOLECULAR GENETICS, 1994, 3 (02) : 237 - 241
  • [4] ENG C, 1995, ONCOGENE, V10, P509
  • [5] MUTATION OF THE RET PROTOONCOGENE IN SPORADIC MEDULLARY-THYROID CARCINOMA
    ENG, C
    MULLIGAN, LM
    SMITH, DP
    HEALEY, CS
    FRILLING, A
    RAUE, F
    NEUMANN, HPH
    PFRAGNER, R
    BEHMEL, A
    LORENZO, MJ
    STONEHOUSE, TJ
    PONDER, MA
    PONDER, BAJ
    [J]. GENES CHROMOSOMES & CANCER, 1995, 12 (03) : 209 - 212
  • [6] NATURAL-HISTORY OF FAMILIAL MEDULLARY-THYROID CARCINOMA
    GRAZE, K
    SPILER, IJ
    TASHJIAN, AH
    MELVIN, KEW
    CERVISKINNER, S
    GAGEL, RF
    MILLER, HH
    WOLFE, HJ
    DELELLIS, RA
    LEAPE, L
    FELDMAN, ZT
    REICHLIN, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (18) : 980 - 985
  • [7] A MUTATION IN THE RET PROTOONCOGENE ASSOCIATED WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE-2B AND SPORADIC MEDULLARY-THYROID CARCINOMA
    HOFSTRA, RMW
    LANDSVATER, RM
    CECCHERINI, I
    STULP, RP
    STELWAGEN, T
    LUO, Y
    PASINI, B
    HOPPENER, JWM
    VANAMSTEL, HKP
    ROMEO, G
    LIPS, CJM
    BUYS, CHCM
    [J]. NATURE, 1994, 367 (6461) : 375 - 376
  • [8] CLINICAL SCREENING AS COMPARED WITH DNA ANALYSIS IN FAMILIES WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A
    LIPS, CJM
    LANDSVATER, RM
    HOPPENER, JWM
    GEERDINK, RA
    BLIJHAM, G
    VANVEEN, JMJS
    VANGILS, APG
    DEWIT, MJ
    ZEWALD, RA
    BERENDS, MJH
    BEEMER, FA
    BROUWERSSMALBRAAK, J
    JANSEN, RPM
    VANAMSTEL, HKP
    VANVROONHOVEN, TJM
    VROOM, TM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (13) : 828 - 835
  • [9] MARSH DJ, 1995, IN PRESS CLIN ENDOCR
  • [10] GERM-LINE MUTATIONS OF THE RET PROTOONCOGENE IN MULTIPLE ENDOCRINE NEOPLASIA TYPE-2A
    MULLIGAN, LM
    KWOK, JBJ
    HEALEY, CS
    ELSDON, MJ
    ENG, C
    GARDNER, E
    LOVE, DR
    MOLE, SE
    MOORE, JK
    PAPI, L
    PONDER, MA
    TELENIUS, H
    TUNNACLIFFE, A
    PONDER, BAJ
    [J]. NATURE, 1993, 363 (6428) : 458 - 460